questionsmedicales.fr
Régions géographiques
Villes
Villes : Questions médicales fréquentes
Termes MeSH sélectionnés :
Histocompatibility Testing
Diagnostic
5
Pollution de l'air
Santé publique
Maladies environnementales
Diagnostic médical
Épidémiologie
Analyse spatiale
Santé urbaine
Épidémiologie
Accès aux soins
Santé publique
Symptômes
5
Pollution de l'air
Symptômes respiratoires
Qualité de l'eau
Maladies infectieuses
Isolement social
Santé mentale
Prévention
5
Prévention
Pollution de l'air
Santé mentale
Espaces verts
Qualité de l'eau
Santé publique
Traitements
5
Maladies respiratoires
Traitement médical
Chaleur
Urgences médicales
Maladies infectieuses
Traitement médical
Anxiété
Traitement médical
Complications
5
Pollution de l'air
Complications médicales
Isolement social
Santé mentale
Chaleur
Urgences médicales
Qualité de l'eau
Maladies infectieuses
Santé mentale
Complications médicales
Facteurs de risque
5
Pollution de l'air
Facteurs de risque
Chaleur
Facteurs de risque
Maladies infectieuses
Facteurs de risque
Comportements de santé
Facteurs de risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Villes : Questions médicales les plus fréquentes",
"headline": "Villes : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Villes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-31",
"dateModified": "2025-04-27",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Villes"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Régions géographiques",
"url": "https://questionsmedicales.fr/mesh/D005842",
"about": {
"@type": "MedicalCondition",
"name": "Régions géographiques",
"code": {
"@type": "MedicalCode",
"code": "D005842",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Baltimore",
"alternateName": "Baltimore",
"url": "https://questionsmedicales.fr/mesh/D015142",
"about": {
"@type": "MedicalCondition",
"name": "Baltimore",
"code": {
"@type": "MedicalCode",
"code": "D015142",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.433.100"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Pékin",
"alternateName": "Beijing",
"url": "https://questionsmedicales.fr/mesh/D000068476",
"about": {
"@type": "MedicalCondition",
"name": "Pékin",
"code": {
"@type": "MedicalCode",
"code": "D000068476",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.433.114"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Boston",
"alternateName": "Boston",
"url": "https://questionsmedicales.fr/mesh/D001900",
"about": {
"@type": "MedicalCondition",
"name": "Boston",
"code": {
"@type": "MedicalCode",
"code": "D001900",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.433.210"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chicago",
"alternateName": "Chicago",
"url": "https://questionsmedicales.fr/mesh/D002641",
"about": {
"@type": "MedicalCondition",
"name": "Chicago",
"code": {
"@type": "MedicalCode",
"code": "D002641",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.433.305"
}
}
},
{
"@type": "MedicalWebPage",
"name": "District de Columbia",
"alternateName": "District of Columbia",
"url": "https://questionsmedicales.fr/mesh/D004219",
"about": {
"@type": "MedicalCondition",
"name": "District de Columbia",
"code": {
"@type": "MedicalCode",
"code": "D004219",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.433.429"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Los Angeles",
"alternateName": "Los Angeles",
"url": "https://questionsmedicales.fr/mesh/D015141",
"about": {
"@type": "MedicalCondition",
"name": "Los Angeles",
"code": {
"@type": "MedicalCode",
"code": "D015141",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.433.565"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Nouvelle-Orléans",
"alternateName": "New Orleans",
"url": "https://questionsmedicales.fr/mesh/D055820",
"about": {
"@type": "MedicalCondition",
"name": "Nouvelle-Orléans",
"code": {
"@type": "MedicalCode",
"code": "D055820",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.433.697"
}
}
},
{
"@type": "MedicalWebPage",
"name": "New York (ville)",
"alternateName": "New York City",
"url": "https://questionsmedicales.fr/mesh/D009519",
"about": {
"@type": "MedicalCondition",
"name": "New York (ville)",
"code": {
"@type": "MedicalCode",
"code": "D009519",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.433.741"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Philadelphie",
"alternateName": "Philadelphia",
"url": "https://questionsmedicales.fr/mesh/D015143",
"about": {
"@type": "MedicalCondition",
"name": "Philadelphie",
"code": {
"@type": "MedicalCode",
"code": "D015143",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.433.820"
}
}
},
{
"@type": "MedicalWebPage",
"name": "San Francisco",
"alternateName": "San Francisco",
"url": "https://questionsmedicales.fr/mesh/D012495",
"about": {
"@type": "MedicalCondition",
"name": "San Francisco",
"code": {
"@type": "MedicalCode",
"code": "D012495",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.433.875"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Séoul",
"alternateName": "Seoul",
"url": "https://questionsmedicales.fr/mesh/D066106",
"about": {
"@type": "MedicalCondition",
"name": "Séoul",
"code": {
"@type": "MedicalCode",
"code": "D066106",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.433.887"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Tokyo",
"alternateName": "Tokyo",
"url": "https://questionsmedicales.fr/mesh/D014041",
"about": {
"@type": "MedicalCondition",
"name": "Tokyo",
"code": {
"@type": "MedicalCode",
"code": "D014041",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.433.900"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Villes",
"alternateName": "Cities",
"code": {
"@type": "MedicalCode",
"code": "D002947",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Divya Seth",
"url": "https://questionsmedicales.fr/author/Divya%20Seth",
"affiliation": {
"@type": "Organization",
"name": "Division of Allergy/Immunology, Department of Pediatrics, Children's Hospital of Michigan, Wayne State University School of Medicine, 3950 Beaubien, 4th Floor, Pediatric Specialty Building, Detroit, MI 48201, USA. Electronic address: dseth@dmc.org."
}
},
{
"@type": "Person",
"name": "Shweta Saini",
"url": "https://questionsmedicales.fr/author/Shweta%20Saini",
"affiliation": {
"@type": "Organization",
"name": "Division of Hospital Medicine, Department of Pediatrics, Children's Hospital of Michigan, Wayne State University School of Medicine, Detroit, MI, USA."
}
},
{
"@type": "Person",
"name": "Pavadee Poowuttikul",
"url": "https://questionsmedicales.fr/author/Pavadee%20Poowuttikul",
"affiliation": {
"@type": "Organization",
"name": "Division of Allergy/Immunology, Department of Pediatrics, Children's Hospital of Michigan, Wayne State University School of Medicine, Detroit, MI, USA."
}
},
{
"@type": "Person",
"name": "Marc Barthelemy",
"url": "https://questionsmedicales.fr/author/Marc%20Barthelemy",
"affiliation": {
"@type": "Organization",
"name": "Université Paris-Saclay, CEA, CNRS, Institut de Physique Théorique, 91191 Gif-sur-Yvette, France."
}
},
{
"@type": "Person",
"name": "Sasha Khomenko",
"url": "https://questionsmedicales.fr/author/Sasha%20Khomenko",
"affiliation": {
"@type": "Organization",
"name": "Institute for Global Health, Barcelona, Spain; Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Virtual crossmatch for deceased donor kidney transplantation in the United States: A survey of histocompatibility lab directors and transplant surgeons.",
"datePublished": "2022-12-27",
"url": "https://questionsmedicales.fr/article/36581507",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.humimm.2022.12.001"
}
},
{
"@type": "ScholarlyArticle",
"name": "External proficiency testing for histocompatibility and immunogenetics in today and future.",
"datePublished": "2024-02-26",
"url": "https://questionsmedicales.fr/article/38469118",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fgene.2024.1294330"
}
},
{
"@type": "ScholarlyArticle",
"name": "A Single-Center Analysis of How HLA Mismatch and Donor-Specific Antibodies Affect Short-Term Outcome After Lung Transplantation: A Pilot Study Before a Country-Wide Histocompatibility Study in Japan.",
"datePublished": "2024-02-06",
"url": "https://questionsmedicales.fr/article/38320866",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.transproceed.2023.12.011"
}
},
{
"@type": "ScholarlyArticle",
"name": "Current HLA testing recommendations to support HCT.",
"datePublished": "2022-07-04",
"url": "https://questionsmedicales.fr/article/35798627",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.humimm.2022.04.008"
}
},
{
"@type": "ScholarlyArticle",
"name": "Three patients highlighting potential pitfalls in platelet refractory testing.",
"datePublished": "2023-02-16",
"url": "https://questionsmedicales.fr/article/36794568",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/trf.17280"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Régions géographiques",
"item": "https://questionsmedicales.fr/mesh/D005842"
},
{
"@type": "ListItem",
"position": 3,
"name": "Villes",
"item": "https://questionsmedicales.fr/mesh/D002947"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Villes - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Villes",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-10",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Villes",
"description": "Comment évaluer l'impact de la pollution urbaine sur la santé ?\nQuels tests sont utilisés pour diagnostiquer les maladies liées aux villes ?\nComment identifier les zones à risque sanitaire en ville ?\nQuels indicateurs de santé sont pertinents en milieu urbain ?\nComment évaluer l'accès aux soins en ville ?",
"url": "https://questionsmedicales.fr/mesh/D002947?mesh_terms=Histocompatibility+Testing#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Villes",
"description": "Quels symptômes sont liés à la pollution de l'air ?\nComment la vie urbaine affecte-t-elle la santé mentale ?\nQuels symptômes sont associés à la chaleur urbaine ?\nQuels signes indiquent une mauvaise qualité de l'eau en ville ?\nQuels symptômes sont liés à l'isolement social en ville ?",
"url": "https://questionsmedicales.fr/mesh/D002947?mesh_terms=Histocompatibility+Testing#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Villes",
"description": "Comment prévenir les maladies liées à la pollution en ville ?\nQuelles mesures peuvent réduire le stress urbain ?\nComment améliorer la qualité de l'eau en milieu urbain ?\nQuelles stratégies aident à prévenir les coups de chaleur ?\nComment favoriser la santé mentale en milieu urbain ?",
"url": "https://questionsmedicales.fr/mesh/D002947?mesh_terms=Histocompatibility+Testing#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Villes",
"description": "Quels traitements sont efficaces contre les maladies respiratoires urbaines ?\nComment traiter les effets de la chaleur extrême en ville ?\nQuels traitements sont disponibles pour le stress urbain ?\nComment traiter les maladies liées à l'eau contaminée ?\nQuels traitements sont recommandés pour l'anxiété urbaine ?",
"url": "https://questionsmedicales.fr/mesh/D002947?mesh_terms=Histocompatibility+Testing#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Villes",
"description": "Quelles complications peuvent survenir à cause de la pollution ?\nQuels risques de santé sont liés à l'isolement social ?\nQuelles complications peuvent résulter de la chaleur extrême ?\nComment la qualité de l'eau affecte-t-elle la santé ?\nQuelles complications sont liées à la vie urbaine ?",
"url": "https://questionsmedicales.fr/mesh/D002947?mesh_terms=Histocompatibility+Testing#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Villes",
"description": "Quels facteurs de risque sont associés à la pollution urbaine ?\nComment le stress urbain influence-t-il la santé ?\nQuels sont les risques liés à la chaleur en milieu urbain ?\nQuels facteurs augmentent le risque de maladies infectieuses en ville ?\nQuels comportements augmentent le risque de problèmes de santé en ville ?",
"url": "https://questionsmedicales.fr/mesh/D002947?mesh_terms=Histocompatibility+Testing#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer l'impact de la pollution urbaine sur la santé ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'impact se mesure par des études épidémiologiques et des indicateurs de santé."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour diagnostiquer les maladies liées aux villes ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de laboratoire, des examens cliniques et des enquêtes de santé sont utilisés."
}
},
{
"@type": "Question",
"name": "Comment identifier les zones à risque sanitaire en ville ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'analyse géospatiale et les données de santé publique aident à identifier ces zones."
}
},
{
"@type": "Question",
"name": "Quels indicateurs de santé sont pertinents en milieu urbain ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les taux de maladies respiratoires, cardiovasculaires et d'obésité sont des indicateurs clés."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'accès aux soins en ville ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'accès se mesure par la distance aux établissements de santé et la disponibilité des services."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à la pollution de l'air ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent toux, essoufflement, irritation des yeux et fatigue."
}
},
{
"@type": "Question",
"name": "Comment la vie urbaine affecte-t-elle la santé mentale ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress, l'anxiété et la dépression sont souvent exacerbés par la vie urbaine."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés à la chaleur urbaine ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent déshydratation, épuisement et coups de chaleur."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une mauvaise qualité de l'eau en ville ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes incluent des maladies gastro-intestinales et des éruptions cutanées."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à l'isolement social en ville ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'isolement peut entraîner des symptômes de dépression et d'anxiété."
}
},
{
"@type": "Question",
"name": "Comment prévenir les maladies liées à la pollution en ville ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des politiques de réduction de la pollution et des campagnes de sensibilisation sont essentielles."
}
},
{
"@type": "Question",
"name": "Quelles mesures peuvent réduire le stress urbain ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Promouvoir des espaces verts et des activités communautaires aide à réduire le stress."
}
},
{
"@type": "Question",
"name": "Comment améliorer la qualité de l'eau en milieu urbain ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des systèmes de filtration et des contrôles réguliers de la qualité de l'eau sont nécessaires."
}
},
{
"@type": "Question",
"name": "Quelles stratégies aident à prévenir les coups de chaleur ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éduquer sur l'hydratation et l'ombre, et créer des refuges frais sont des stratégies clés."
}
},
{
"@type": "Question",
"name": "Comment favoriser la santé mentale en milieu urbain ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Encourager le soutien social et l'accès à des services de santé mentale est crucial."
}
},
{
"@type": "Question",
"name": "Quels traitements sont efficaces contre les maladies respiratoires urbaines ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les bronchodilatateurs, corticostéroïdes et thérapies respiratoires sont courants."
}
},
{
"@type": "Question",
"name": "Comment traiter les effets de la chaleur extrême en ville ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement inclut l'hydratation, le repos et, si nécessaire, des soins médicaux."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour le stress urbain ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie cognitivo-comportementale et les médicaments peuvent aider à gérer le stress."
}
},
{
"@type": "Question",
"name": "Comment traiter les maladies liées à l'eau contaminée ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement inclut l'hydratation, des antibiotiques et des soins symptomatiques."
}
},
{
"@type": "Question",
"name": "Quels traitements sont recommandés pour l'anxiété urbaine ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les thérapies psychologiques et les médicaments anxiolytiques sont souvent prescrits."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir à cause de la pollution ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des maladies respiratoires chroniques et des cancers."
}
},
{
"@type": "Question",
"name": "Quels risques de santé sont liés à l'isolement social ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'isolement peut entraîner des maladies cardiovasculaires et des troubles mentaux."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent résulter de la chaleur extrême ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des coups de chaleur, des déshydratations sévères et des décès."
}
},
{
"@type": "Question",
"name": "Comment la qualité de l'eau affecte-t-elle la santé ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une mauvaise qualité de l'eau peut entraîner des infections et des maladies gastro-intestinales."
}
},
{
"@type": "Question",
"name": "Quelles complications sont liées à la vie urbaine ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'anxiété, la dépression et des maladies chroniques."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque sont associés à la pollution urbaine ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'industrialisation, le trafic routier et l'urbanisation rapide."
}
},
{
"@type": "Question",
"name": "Comment le stress urbain influence-t-il la santé ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress peut aggraver des conditions comme l'hypertension et l'anxiété."
}
},
{
"@type": "Question",
"name": "Quels sont les risques liés à la chaleur en milieu urbain ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes âgées et celles avec des maladies chroniques sont particulièrement à risque."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de maladies infectieuses en ville ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "La densité de population et l'accès limité à l'eau potable augmentent les risques."
}
},
{
"@type": "Question",
"name": "Quels comportements augmentent le risque de problèmes de santé en ville ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabagisme, la sédentarité et une alimentation déséquilibrée sont des comportements à risque."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 27/04/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Division of Allergy/Immunology, Department of Pediatrics, Children's Hospital of Michigan, Wayne State University School of Medicine, 3950 Beaubien, 4th Floor, Pediatric Specialty Building, Detroit, MI 48201, USA. Electronic address: dseth@dmc.org.
Publications dans "Villes" :
3 publications dans cette catégorie
Affiliations :
Division of Hospital Medicine, Department of Pediatrics, Children's Hospital of Michigan, Wayne State University School of Medicine, Detroit, MI, USA.
Publications dans "Villes" :
3 publications dans cette catégorie
Affiliations :
Division of Allergy/Immunology, Department of Pediatrics, Children's Hospital of Michigan, Wayne State University School of Medicine, Detroit, MI, USA.
Publications dans "Villes" :
2 publications dans cette catégorie
Affiliations :
Université Paris-Saclay, CEA, CNRS, Institut de Physique Théorique, 91191 Gif-sur-Yvette, France.
Centre d'Analyse et de Mathématique Sociales, (CNRS/EHESS) 54, Boulevard Raspail, 75006 Paris, France.
Publications dans "Villes" :
2 publications dans cette catégorie
Affiliations :
Institute for Global Health, Barcelona, Spain; Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Publications dans "Villes" :
2 publications dans cette catégorie
Affiliations :
Institute for Global Health, Barcelona, Spain; Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Publications dans "Villes" :
2 publications dans cette catégorie
Affiliations :
Institute for Global Health, Barcelona, Spain; Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. Electronic address: mark.nieuwenhuijsen@isglobal.org.
Publications dans "Villes" :
2 publications dans cette catégorie
Affiliations :
Health Liveable Cities Lab, Centre for Urban Research, RMIT University, Melbourne, Victoria, Australia. Electronic address: billie.giles-corti@rmit.edu.au.
Publications dans "Villes" :
2 publications dans cette catégorie
Affiliations :
Melbourne Centre for Cities, University of Melbourne, Melbourne, Victoria, Australia.
Publications dans "Villes" :
2 publications dans cette catégorie
Affiliations :
Health Liveable Cities Lab, Centre for Urban Research, RMIT University, Melbourne, Victoria, Australia.
Publications dans "Villes" :
1 publication dans cette catégorie
Affiliations :
Lee Kuan Yew Centre for Innovative Cities, Singapore University of Technology and Design, 8 Somapah Road, #02-302, Building 3 Level 2, Singapore 487372.
Publications dans "Villes" :
1 publication dans cette catégorie
Affiliations :
Lee Kuan Yew Centre for Innovative Cities, Singapore University of Technology and Design, 8 Somapah Road, #02-302, Building 3 Level 2, Singapore 487372.
Publications dans "Villes" :
1 publication dans cette catégorie
Affiliations :
Adam Mickiewicz University in Poznań, Faculty of Human Geography and Planning, ul. B. Krygowskiego 10, 61-680 Poznań, Poland.
Publications dans "Villes" :
1 publication dans cette catégorie
Affiliations :
Adam Mickiewicz University in Poznań, Faculty of Human Geography and Planning, ul. B. Krygowskiego 10, 61-680 Poznań, Poland.
Publications dans "Villes" :
1 publication dans cette catégorie
Affiliations :
Department of Archaeogenetics, Max Planck Institute for the Science of Human History, Jena, Germany; Molecular Genetics Laboratory, Escuela Nacional de Antropología e Historia (ENAH), Mexico City, Mexico. Electronic address: barquera@shh.mpg.de.
Publications dans "Villes" :
1 publication dans cette catégorie
Affiliations :
HLA Laboratory, Central Blood Bank, Hospital de Especialidades, Unidad Médica de Alta Especialidad (UMAE) Centro Médico Nacional "Siglo XXI", Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico.
Publications dans "Villes" :
1 publication dans cette catégorie
Affiliations :
Molecular Genetics Laboratory, Escuela Nacional de Antropología e Historia (ENAH), Mexico City, Mexico; Immunogenetics Unit, Técnicas Genéticas Aplicadas a la Clínica (TGAC), Mexico City, Mexico.
Publications dans "Villes" :
1 publication dans cette catégorie
Affiliations :
Blood Bank, UMAE Hospital de Gineco Obstetricia No. 4 "Luis Castelazo Ayala", Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico.
Publications dans "Villes" :
1 publication dans cette catégorie
Affiliations :
Molecular Immunogenetics Laboratory, Instituto Nacional de Pediatría (INP), Mexico City, Mexico.
Publications dans "Villes" :
1 publication dans cette catégorie
Affiliations :
Histocompatibility Laboratory, Central Blood Bank, Centro Médico Nacional "La Raza", Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico.
Publications dans "Villes" :
Virtual crossmatch (VXM) is used as an alternative to or in conjunction with a cell-based physical crossmatch (PXM) for assessing HLA (human leukocyte antigen) compatibility prior to deceased donor ki...
The Histocompatibility and Immunogenetics laboratories provide disease association and pharmacogenetic analyses as well as the tests required for transplantation immunology and transfusion medicine. T...
Analyzing HLA polymorphism in lung transplantation (LTx) is important, given its impact on LTx recipient survival and graft function. Accordingly, we conducted a retrospective study to examine the inf...
HLA antigen or eplet mismatch in LTx patients at Tohoku University Hospital from 2018 to 2023 was determined, and DSA was measured on admission for surgery to identify preformed DSA and at weeks 4 to ...
The participants were 45 LTx recipients, HLA-A/B/DR antigen mismatch (5-6 of 6) being identified in 57%, HLA-A/B/Cw/DR/DQ mismatch (8-10 of 10) in 57%, and HLA eplet mismatch (>61) in 46%. The prevale...
Despite limitations in sample size, resulting in tentative findings, the study serves as a crucial pilot study for an ongoing multicenter prospective trial in Japan....
Supporting allogeneic hematopoietic cell transplantation (HCT) is an integral function of the clinical HLA laboratory, which provides HLA testing for recipients and donors. However, the timing, scope,...
Platelet-transfusion refractory (PR) patients do not achieve expected post-transfusion platelet counts. We investigate suspected PR patients with post-transfusion platelet counts, indirect platelet an...
The three following cases describe possible pitfalls of laboratory tests used in PR workup and management....
Case #1: Antibody testing detected antibodies to only HLA-B13, corresponding to a 4% calculated panel reactive antibodies (CPRA; 96% predicted donor compatibility). However, PXM showed the patient com...
These cases highlight the importance of investigating incongruent results. Cases #1 and #2 demonstrate PXM pitfalls: ABO incompatibility can result in positive PXM and false-negative PXM can occur in ...
Patients undergoing recurrent platelet transfusions can become refractory to these transfusions. Platelet antibody screens (Immucor), platelet crossmatching assays (Immucor), and HLA antibody testing ...
The Histocompatibility and Identity Testing Committee offers an overview of the College of American Pathologists' (CAP) Proficiency Testing (PT) program, commemorating its significant 75th anniversary...
GATA1-related cytopenia (GRC) is characterized by thrombocytopaenia and/or anaemia ranging from mild to severe. Haematopoietic stem cell transplantation (HSCT) is a healing therapeutic choice for GRC ...
The proband is a 6-year-old boy who was diagnosed to have transfusion-dependent anaemia since 3 year old. Whole-exome sequencing (WES) showed that the proband has a hemizygous variant c.1019delG in GA...
NGS-based PGT-HLA is a valuable procedure for the treatment of GATA1-related cytopenia caused by GATA1 variants, or other haematological disorders, oncological and immunological diseases. Furthermore,...
HLA antibody testing is essential for successful solid-organ allocation, patient monitoring post-transplant, and risk assessment for both solid-organ and hematopoietic transplant patients. Luminex sol...
In our study, solid organ transplant patients who exhibited HLA donor-specific antibodies (DSAs) were used to characterize the utility of PCA-derived analysis when compared to a control group of post-...
PCA-derived analysis would be ideal to help automatically identify patient samples that have an HLA antibody pattern of reactivity consistent with their history and those which exhibit changes in thei...
Parkinson's disease (PD) is a common neurodegenerative disease characterized by progressive loss of dopaminergic neurons in the substantia nigra and the aggregation of alpha-synuclein (α-syn). The cen...